Abingworth

What they do

Abingworth is a life sciences investment firm that partners with biopharma entrepreneurs to turn scientific discoveries into new medical treatments. The firm has invested in more than a hundred young biopharma companies since its first biotech investment in 1987, supporting them with capital, expertise, and novel investment structures such as venture investments in public equities and clinical co-development. Abingworth operates with a transatlantic presence through offices in London, New York, and San Francisco, maintaining close access to key biotech hubs.

What they look for

Abingworth's stated mission is "working with entrepreneurs to turn breakthrough science into breakthrough medicine." They look for game-changers and paradigm-shifts that will materially improve patients' lives, rather than incremental improvements. They explicitly seek out biopharma, therapeutics, diagnostics, and medical device companies, looking for top-caliber management teams and cutting-edge science that can be translated into novel medicines.

Stage

Seed, Series A, Series B+

Sectors

Healthcare, AI

Based

London, GB